Streetbeat News

Products Services

INO

INOVIO presented promising data on its lead candidate, INO-3107, showing its potential to treat HPV-related diseases by inducing T cell responses. The data supports INO-3107's ability to reduce surgical interventions in RRP patients, with a Biologics License Application planned for mid-2025.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 12:03 pm

TARA

Protara Therapeutics' IV Choline Chloride has received FDA Fast Track designation, highlighting its potential as the first approved IV choline therapy for patients on parenteral support. The company plans to start a pivotal clinical trial in early 2025.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 12:01 pm

IBM

META

NVDA

VIG

VYM

IBM has launched Granite 3.0, a new family of open-source AI models, at its TechXchange event. These models aim to enhance AI transparency, safety, and performance for enterprises. IBM's initiative is part of a broader trend in AI development, with companies like Nvidia and Meta also making strides in open-source AI. Analyst Dan Ives predicts a positive outlook for tech stocks, including IBM, driven by the AI boom.

Portfolio Pulse from Anusuya Lahiri

October 21, 2024 | 12:00 pm

SYTA

Siyata Mobile's shares rose following the announcement that its new SD7 Ultra series 5G push-to-talk handsets will be available on T-Mobile's 5G network.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:47 am

GOOGL

HON

Honeywell has signed a deal with Google to integrate Google's Gemini Generative AI into the industrial sector. This partnership aims to enhance industrial operations through advanced AI capabilities.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:46 am

ARMK

Aramark (NYSE:ARMK) has partnered with Asbury Communities to enhance dining services in five of Asbury's senior living communities. The collaboration aims to improve residents' well-being through Aramark's SeniorLIFE+ services, focusing on culinary, nutrition, and hospitality.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:37 am

SEDG

SolarEdge's portfolio of PV inverters has achieved early certification and compliance with the European Commission's new Radio Equipment Directive requirements for wireless connected products. This positions SolarEdge favorably in the European market.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:36 am

TRVI

Trevi Therapeutics has completed enrollment in its Phase 2a RIVER trial for treating refractory chronic cough. This milestone is significant for the company's development pipeline and could impact its stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:34 am

SEED

Origin Agritech Ltd. (NASDAQ:SEED) has launched the 'Origin Marker Biological Breeding Service Consortium' in partnership with China Golden Marker Biotechnology Co., Ltd. to accelerate GMO and gene editing technologies in China. The consortium aims to license Origin's GMO traits and gene editing technology to a wider range of industry players, promoting commercialization and innovation in maize breeding.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:34 am

ELAB

Elevai Labs' subsidiary, Elevai Biosciences, has highlighted past preclinical data from 2022 on their product EL-32. The data showed statistically significant improvements in grip strength, motor function, and body composition in an aged mouse model.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:34 am